Reversal of GATA-6 downregulation promotes smooth muscle differentiation and inhibits intimal hyperplasia in balloon-injured rat carotid artery.

No abstract is available for this paper.

• Publication year

  1999

• Venue

  Circulation Research

• Publication date

  1999-04-02

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1161/01.RES.84.6.647PMID 10189352
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Cell cycle progression: new therapeutic target for vascular proliferative disease.

  1998cited by this paper
• Common role for each of the cGATA-4/5/6 genes in the regulation of cardiac morphogenesis.

  1998cited by this paper
• Combinatorial interactions regulating cardiac transcription.

  1998cited by this paper
• GATA-6 Induces p21Cip1 Expression and G1Cell Cycle Arrest*

  1998cited by this paper
• Temporally and spatially coordinated expression of cell cycle regulatory factors after angioplasty.

  1997cited by this paper
• Enhanced cardiogenesis in embryonic stem cells overexpressing the GATA-4 transcription factor.

  1997cited by this paper
• GATA4 transcription factor is required for ventral morphogenesis and heart tube formation.

  1997cited by this paper
• Evidence for the rapid onset of apoptosis in medial smooth muscle cells after balloon injury.

  1997cited by this paper
• Requirement of the transcription factor GATA4 for heart tube formation and ventral morphogenesis.

  1997cited by this paper
• The cardiac transcription factors Nkx2‐5 and GATA‐4 are mutual cofactors

  1997cited by this paper
• p21CIP1-mediated inhibition of cell proliferation by overexpression of the gax homeodomain gene.

  1997cited by this paper
• Adenoviral constructs encoding phosphorylation-competent full-length and truncated forms of the human retinoblastoma protein inhibit myocyte proliferation and neointima formation.

  1997cited by this paper
• Electron microscopic studies of phenotypic modulation of smooth muscle cells in coronary arteries of patients with unstable angina pectoris and postangioplasty restenosis.

  1997cited by this paper
• Expression rate of vinculin isoforms in human aortocoronary saphenous vein grafts.

  1997cited by this paper
• The human GATA-6 gene: structure, chromosomal location, and regulation of expression by tissue-specific and mitogen-responsive signals.

  1996cited by this paper
• Molecular strategies to inhibit restenosis: modulation of the vascular myocyte phenotype.

  1996cited by this paper
• GATA-6: a zinc finger transcription factor that is expressed in multiple cell lineages derived from lateral mesoderm.

  1996cited by this paper
• Distinct gene expression patterns in skeletal and cardiac muscle are dependent on common regulatory sequences in the MLC1/3 locus

  1996cited by this paper
• The Xenopus GATA-4/5/6 genes are associated with cardiac specification and can regulate cardiac-specific transcription during embryogenesis.

  1996cited by this paper
• Cytostatic gene therapy for vascular proliferative disorders with a constitutively active form of the retinoblastoma gene product

  1995cited by this paper
• Regulation of differentiation of vascular smooth muscle cells.

  1995cited by this paper
• Adenovirus-mediated over-expression of the cyclin/cyclin-dependent kinase inhibitor, p21 inhibits vascular smooth muscle cell proliferation and neointima formation in the rat carotid artery model of balloon angioplasty.

  1995cited by this paper
• Small stent size and intimal hyperplasia contribute to restenosis: a volumetric intravascular ultrasound analysis.

  1995cited by this paper
• Gotta have GATA

  1995cited by this paper
• Expression of gax, a Growth Arrest Homeobox Gene, Is Rapidly Down-regulated in the Rat Carotid Artery during the Proliferative Response to Balloon Injury (*)

  1995cited by this paper
• Inhibition of transcription factor GATA-4 expression blocks in vitro cardiac muscle differentiation

  1995cited by this paper
• Mitogen-responsive nuclear factors that mediate growth control signals in vascular myocytes.

  1995cited by this paper
• Intimal hyperplasia after vascular injury is inhibited by antisense cdk 2 kinase oligonucleotides.

  1994cited by this paper
• The pathogenesis of atherosclerosis: a perspective for the 1990s

  1993cited by this paper
• Human smooth muscle myosin heavy chain isoforms as molecular markers for vascular development and atherosclerosis.

  1993cited by this paper
• Influence of animal age on the beta-adrenergic system in cultured rat aortic and mesenteric artery smooth muscle cells.

  1992cited by this paper
• Genotoxic‐Stress‐Response Genes and Growth‐Arrest Genes

  1992cited by this paper
• Adenovirus-based expression vectors and recombinant vaccines.

  1992cited by this paper
• Murine and human T-lymphocyte GATA-3 factors mediate transcription through a cis-regulatory element within the human T-cell receptor delta gene enhancer

  1991cited by this paper
• A review of the histologic changes in vein-to-artery grafts, with particular reference to intimal hyperplasia.

  1988cited by this paper
• Modulation of human aorta smooth muscle cell phenotype: a study of muscle-specific variants of vinculin, caldesmon, and actin expression.

  1988cited by this paper
• Genes specifically expressed at growth arrest of mammalian cells.

  1988cited by this paper
• Vascular smooth muscle in culture

  1987cited by this paper
• Kinetics of cellular proliferation after arterial injury. I. Smooth muscle growth in the absence of endothelium.

  1983cited by this paper
• The smooth muscle cell in culture.

  1979cited by this paper
• A new technique for the assay of infectivity of human adenovirus 5 DNA.

  1973cited by this paper

• miPEP31 inhibits the vascular smooth muscle cell proliferation via cooperation with transcription factor Trps1

  2025cites this paper
• A CEBPB/miR-32-5p/GATA6 Axis Promotes Vascular Calcification in Type 2 Diabetes.

  2024cites this paper
• SWI/SNF Complex in Vascular Smooth Muscle Cells and Its Implications in Cardiovascular Pathologies

  2024cites this paper
• GATA6 triggers fibroblast activation and tracheal fibrosis through the Wnt/β-catenin pathway.

  2023cites this paper
• GATA6 coordinates cross-talk between BMP10 and oxidative stress axis in pulmonary arterial hypertension

  2023cites this paper
• Endothelial Gata6 deletion reduces monocyte recruitment and proinflammatory macrophage formation and attenuates atherosclerosis through Cmpk2-Nlrp3 pathways

  2023cites this paper
• Transcription factor GATA6 promotes migration of human coronary artery smooth muscle cells in vitro

  2022cites this paper
• GATA6 is a crucial factor for Myocd expression in the visceral smooth muscle cell differentiation program of the murine ureter.

  2022cites this paper
• Cytokine‐induced apoptosis inhibitor 1 (CIAPIN1) accelerates vascular remodelling via p53 and JAK2‐STAT3 regulation in vascular smooth muscle cells

  2021cites this paper
• Effect of Erythropoietin on Calcification of Vascular Smooth Muscle Cells and Its Molecular Regulatory Mechanism

  2020cites this paper
• TWIST1 Drives Smooth Muscle Cell Proliferation in Pulmonary Hypertension via Loss of GATA-6 and BMPR2.

  2020cites this paper
• A Rat Carotid Artery Pressure-Controlled Segmental Balloon Injury with Periadventitial Therapeutic Application.

  2020cites this paper
• Genetic variations in the transcription factors GATA4 and GATA6 and bleeding complications in patients receiving warfarin therapy

  2019cites this paper
• Genetic and Functional Variants Analysis of the GATA6 Gene Promoter in Acute Myocardial Infarction

  2019cites this paper
• Nuclear Focal Adhesion Kinase.

  2019cites this paper
• Cell-Specific Effects of GATA (GATA Zinc Finger Transcription Factor Family)-6 in Vascular Smooth Muscle and Endothelial Cells on Vascular Injury Neointimal Formation

  2019cites this paper
• Chromatin Conformation Links Putative Enhancers in Intracranial Aneurysm–Associated Regions to Potential Candidate Genes

  2019cites this paper
• Nuclear Focal Adhesion Kinase Controls Vascular Smooth Muscle Cell Proliferation and Neointimal Hyperplasia Through GATA4-mediated Cyclin D1 Transcription.

  2019cites this paper
• DDDT_A_198018 1717..1727

  2019cites this paper
• Direct Reprogramming of Fibroblasts Into Smooth Muscle-Like Cells With Defined Transcription Factors—Brief Report

  2018cites this paper
• O-Linked &bgr;-N-Acetylglucosamine Modification of A20 Enhances the Inhibition of NF-&kgr;B (Nuclear Factor-&kgr;B) Activation and Elicits Vascular Protection After Acute Endoluminal Arterial Injury

  2018cites this paper
• TCF7L2 (Transcription Factor 7-Like 2) Regulation of GATA6 (GATA-Binding Protein 6)-Dependent and -Independent Vascular Smooth Muscle Cell Plasticity and Intimal Hyperplasia

  2018influential citation
• Longitudinal patterning in roots: a GATA2–auxin interaction underlies and maintains the root transition domain

  2018cites this paper
• Inflammation and vascular smooth muscle cell dedifferentiation following carotid artery ligation.

  2017cites this paper
• Regulator of G protein signaling 4 is a novel target of GATA-6 transcription factor.

  2017cites this paper
• Rôle des cellules musculaires lisses vasculaires et des intégrines dans la génération de thrombine dans le compartiment sanguin et vasculaire

  2016cites this paper
• Histone deacetylase and GATA-binding factor 6 regulate arterial remodeling in angiotensin II-induced hypertension

  2016cites this paper
• Noncoding RNAs in smooth muscle cell homeostasis: implications in phenotypic switch and vascular disorders

  2016cites this paper
• Signal-Dependent Transcriptional Regulation of Vascular Smooth Muscle Cell Differentiation

  2015cites this paper
• Molecular Mechanisms of Smooth Muscle and Fibroblast Phenotype Conversions in the Failing Heart

  2015cites this paper
• Phosphorylation of GATA-6 is required for vascular smooth muscle cell differentiation after mTORC1 inhibition

  2015influential citation
• Nanoparticle Drug- and Gene-eluting Stents for the Prevention and Treatment of Coronary Restenosis

  2014cites this paper
• La semicarbazide-sensitive amine oxydase : son rôle dans la différenciation cellulaire des chondrocytes et des cellules musculaires lisses vasculaires et son implication dans des pathologies articulaires et cardiovasculaires

  2014cites this paper
• GATA6, SF1, NGFIB and DAX1 in the remodeled subcapsular zones in primary aldosteronism.

  2014cites this paper
• Identification of two novel GATA6 mutations in patients with nonsyndromic conotruncal heart defects.

  2014cites this paper
• Alternative approaches to the prevention of coronary In-stent restenosis

  2014cites this paper
• The use of external mesh reinforcement to reduce intimal hyperplasia and preserve the structure of human saphenous veins.

  2014cites this paper
• Endothelial GATA-6 deficiency promotes pulmonary arterial hypertension.

  2013cites this paper
• GATA 6 predicts prognosis and hepatic metastasis of colorectal cancer

  2013cites this paper
• Up-regulation of Fas ligand expression by sirtuin 1 in both flow-restricted vessels and serum-stimulated vascular smooth muscle cells.

  2013cites this paper
• VASCULAR BIOLOGY , ATHEROSCLEROSIS , AND ENDOTHELIUM BIOLOGY Endothelial GATA-6 De fi ciency Promotes Pulmonary Arterial Hypertension

  2013cites this paper
• GATA6 predicts prognosis and hepatic metastasis of colorectal cancer.

  2013cites this paper
• Molecular Control of Smooth Muscle Cell Differentiation Marker Genes by Serum Response Factor and Its Interacting Proteins

  2012cites this paper
• SIRT1 inhibits angiotensin II-induced vascular smooth muscle cell hypertrophy.

  2011cites this paper
• Vascular smooth-muscle-cell activation: proteomics point of view.

  2011cites this paper
• Cell signaling pathways for the regulation of GATA4 transcription factor: Implications for cell growth and apoptosis.

  2011cites this paper
• Transcription factor GATA-6 is expressed in quiescent myofibroblasts in idiopathic pulmonary fibrosis.

  2010cites this paper
• Cellular and molecular aspects of vascular dysfunction in systemic sclerosis

  2010cites this paper
• Vascular smooth muscle cell differentiation-2010

  2010cites this paper
• Real-time monitoring of relaxation and contractility of smooth muscle cells on a novel biohybrid chip.

  2010cites this paper
• GATA6 promotes colon cancer cell invasion by regulating urokinase plasminogen activator gene expression.

  2010cites this paper
• GATA6 Promotes Angiogenic Function and Survival in Endothelial Cells by Suppression of Autocrine Transforming Growth Factor β/Activin Receptor-like Kinase 5 Signaling*

  2010cites this paper
• GATA4 in Heart Development and Disease

  2010cites this paper
• In Vitro Vascular Cell Culture Systems – Vascular Smooth Muscle

  2010cites this paper
• Angiotensin II–Inducible Smooth Muscle Cell Apoptosis Involves the Angiotensin II Type 2 Receptor, GATA-6 Activation, and FasL-Fas Engagement

  2009cites this paper
• Simvastatin Restores Down-Regulated GATA-6 Expression in Pulmonary Hypertensive Rats

  2009cites this paper
• Targeted endothelial nitric oxide synthase gene delivery with lipopolyplexes for the treatment of coronary restenosis

  2009cites this paper
• Transcription factors GATA-4 and GATA-6 in normal and neoplastic human gastrointestinal mucosa

  2008cites this paper
• Statins activate GATA-6 and induce differentiated vascular smooth muscle cells.

  2008cites this paper
• GATA-6 is a novel transcriptional repressor of the human Tenascin-C gene expression in fibroblasts.

  2008cites this paper
• Regulation of vascular smooth muscle cell differentiation.

  2007cites this paper
• Nanoparticulate carriers for the treatment of coronary restenosis

  2007cites this paper
• Regulatory issues surrounding nanomedicines: setting the scene for the next generation of nanopharmaceuticals.

  2007cites this paper
• Chapter 4 Regulation of vascular smooth muscle cell differentiation

  2007influential citation
• Transcription factor CHF1/Hey2 regulates the global transcriptional response to platelet-derived growth factor in vascular smooth muscle cells.

  2007cites this paper
• Resting smooth muscle cells as a model for studying vascular cell activation.

  2006cites this paper
• Vascular smooth muscle cell phenotypic plasticity and the regulation of vascular calcification

  2006cites this paper
• GATA-6 regulates semaphorin 3C and is required in cardiac neural crest for cardiovascular morphogenesis.

  2006cites this paper
• CHF1/Hey2 suppresses SM-MHC promoter activity through an interaction with GATA-6.

  2006cites this paper
• Smooth muscle alpha-actin deficiency in myofibroblasts leads to enhanced renal tissue fibrosis.

  2006cites this paper
• Gene transfer therapy in vascular diseases.

  2006cites this paper
• Smooth Muscle α-Actin Deficiency in Myofibroblasts Leads to Enhanced Renal Tissue Fibrosis*

  2006cites this paper
• Regulation of myosin light chain kinase and telokin expression in smooth muscle tissues.

  2006cites this paper
• Gene therapy of fibroproliferative vasculopathies: current ideas in molecular mechanisms and biomedical technology.

  2006cites this paper
• Advances towards Cerebrovascular Gene Therapy

  2005cites this paper
• GATA-6 Can Act as a Positive or Negative Regulator of Smooth Muscle-specific Gene Expression*

  2005cites this paper
• Characterization of Mesenchyme Homeobox 2 (MEOX2) transcription factor binding to RING finger protein 10

  2005cites this paper
• Suppression of cancer phenotypes through a multifunctional actin‐binding protein, calponin, that attacks cancer cells and simultaneously protects the host from invasion

  2005cites this paper
• Transforming Growth Factor-β1-induced Expression of Smooth Muscle Marker Genes Involves Activation of PKN and p38 MAPK*

  2005cites this paper
• Activation of the Ca2+/calcineurin/NFAT2 pathway controls smooth muscle cell differentiation

  2005cites this paper
• Cells GATA-6 Regulates Genes Promoting Synthetic Functions in Vascular Smooth Muscle

  2005cites this paper
• Gene Therapy for Celebral Arterial Diseases

  2005cites this paper
• Activation of the Ca(2+)/calcineurin/NFAT2 pathway controls smooth muscle cell differentiation.

  2005cites this paper
• Transforming growth factor-beta1-induced expression of smooth muscle marker genes involves activation of PKN and p38 MAPK.

  2005cites this paper
• Smooth Muscle-Specific Genes Are Differentially Sensitive to Inhibition by Elk-1

  2005cites this paper
• Transcription factors GATA-6, SF-1, and cell proliferation in human adrenocortical tumors.

  2005cites this paper
• Calcineurin initiates smooth muscle differentiation in neural crest stem cells

  2004cites this paper
• Gene therapy for restenosis--what now, what next?

  2004cites this paper
• Regulation of cardiac myocyte apoptosis by the GATA-4 transcription factor.

  2004cites this paper
• Combinatorial Control of Smooth Muscle–Specific Gene Expression

  2003cites this paper
• c-Myc Oncoprotein: Cell Cycle-Related Events and New Therapeutic Challenges in Cancer and Cardiovascular Diseases

  2003cites this paper
• Expression of transcription factors and matrix genes in response to serum stimulus in vascular smooth muscle cells.

  2003cites this paper
• Regulation of vascular smooth muscle cell growth: targeting the final common pathway.

  2003cites this paper
• L-Ascorbic Acid Stimulates Expression of Smooth Muscle-Specific Markers in Smooth Muscle Cells both In Vitro and In Vivo

  2003cites this paper
• Regulating the regulators: transcription factors as targets for attenuating proliferative arteriopathies.

  2003cites this paper
• Break the Cycle: The Role of Cell-Cycle Modulation in the Prevention of Vasculoproliferative Diseases

  2003cites this paper
• Activation of GATA-4 by Serotonin in Pulmonary Artery Smooth Muscle Cells*

  2003cites this paper
• Regulation of smooth muscle phenotype

  2003cites this paper
• Inhibition of alveolarization and altered pulmonary mechanics in mice expressing GATA-6.

  2003cites this paper
• GATA-6 Is Involved in PPAR&ggr;-Mediated Activation of Differentiated Phenotype in Human Vascular Smooth Muscle Cells

  2003cites this paper